|
Market Closed -
NYSE
16:00:00 2026-08-14 EDT
|
5-day change | 1st Jan Change | ||
| 0.5374 USD | -14.78% |
|
-30.68% | -89.49% |
| 08-14 | VolitionRx Limited, Q2 2026 Earnings Call, Aug 14, 2026 | |
| 08-13 | VolitionRx Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| VOLITIONRX LIMITED | Bio Diagnostics & Testing | -14.78% | -30.68% | -89.49% | -95.83% | -99.17% | 4.48M |  | | |
- Stock Market
- Stocks
- VNRX Stock
- Charts VolitionRx Limited
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
